Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: goldsachstrader	12/1/2009 11:39:40 PM
	Read Replies (2) of 63325

Ok, tomm is the big day for annual meeting. Well let me say that i will be attending and asking many a question. (1) what happened to the secondary, does immu have an investment advisors, (2)why the hell didnt we do a secondary at (ex. 20 million shares at $6)- enough cash to last us 3+years when biotech was hot, (2a)who is responsible for the business/money decisions at immu, (3)why dont we have a conf call, (4) how is it that Immu has been around for 20years and we only have one (decent) analyst coverage, is it a reflection from the street/firms that they have no belief in immu, (5) Do we expect a milestone payment from UCB/Nyco in the near future, (6) What is going on with the auction rate securities? been in this stock long time and might take some frustration out on the good doctor tomm.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next